Fetal bovine serum (FBS) is a common component of animal cell culture media. It is harvested from bovine fetuses taken from pregnant cows during slaughter. FBS is commonly harvested by means of a cardiac puncture without any form of anaesthesia. Fetuses are probably exposed to pain and/or discomfort, so the current practice of fetal blood harvesting is inhumane. Apart from moral concerns, several scientific and technical problems exist with regard to the use of FBS in cell culture. Efforts should be made to reduce the use of FBS or, preferably, to replace it with synthetic alternatives.
WeiheW.H. (1985). Use and misuse of an imprecise concept: alternative methods in animal experiments. Laboratory Animals19, 19–26.
2.
van ZutphenL.F.M., BaumansV., & BeynenA.C. eds (2001). Principles of Laboratory Animal Science, 2nd edn, 416 pp. Amsterdam, The Netherlands: Elsevier Science Publishers.
3.
GardnerD.K. (1998). Development of serum-free media for the culture and transfer of human blastocysts. Human Reproduction14, Suppl. 4, 218–225.
4.
BallsM., GoldbergA.M., FentemJ.H., BroadheadC.L., BurchR.L., FestingM.F.W., FrazierJ.M., HendriksenC.F.M., JenningsM., van der KampM.D.O., MortonD.B., RowanA.N., RussellC., RussellW.M.S., SpielmannH., StephensM.L., StokesW.S., StraughanD.W., YagerJ.D., ZurloJ., & van ZutphenL.F.M. (1995). The Three Rs: the way forward. ATLA23, 838–866.
5.
KohlpothM., & RuscheB. (1997). Kultivierung einer permanenten Fischzellinie in serumfreien Medien: Spezielle Erfahrungen mit einem Zyto-toxizitätstest für Abwasserproben. ALTEX14, 16–20.
6.
KohlpothM. (1998). Kultivierung von Zellinien in serumfreien Medien: Generelle Vorteile und spezielle Erfahrungen in einem Zytotoxizitätstest mit Fischzellen. In Ersatz - und Ergänzungsmethoden zu Tierversuchen. Forschung ohne Tierverusche 1997 (ed. SchöfflH., SpielmannH., & TritthartH.A.), pp. 15–23. Vienna, Austria: Springer Wien.
DawesG.S. (1968). Foetal and Neonatal Physiology, 247 pp. Chicago, IL, USA: Year Book Medical Publishers.
13.
RosenfeldM., & SnyderF.F. (1938). Stages of development of respiratory regulation and the changes occurring at birth. American Journal of Physiology121, 242–249.
14.
GlassH.G., SnyderF.F., & WebsterE. (1944). The rate of decline in resistance to anoxia of rabbits, dogs, and guinea pigs from the onset of viability to adult life. American Journal of Physiology140, 609–615.
15.
AveryR.C., & JohlinJ.M. (1932). Relative susceptibility of adult and young mice to asphyxation. Proceedings of the Society of Experimental Biology and Medicine29, 1184–1186.
16.
ReissM. (1931). Das Verhalten des Stoffwechsels bei der Erstickung neugeborener Ratten und Mäuse. Zeitschrift für Die Gesamte Experimentelle Medizin79, 345–359.
17.
ReissM., & HaurowitzF. (1929). über das verhalten junger und alter Tiere bei Erstickung. Klinische Wochenschrift8, 743–744.
18.
WoolleyS.C., & GentleM.J. (1988). Physiological and behavioural responses of the domestic hen to hypoxia. Research in Veterinary Science45, 377–382.
19.
KabatH. (1940). The greater resistance of very young animals to arrest of the brain circulation. American Journal of Physiology130, 588–599.
20.
RichardsonB.S. (1992). Metabolism of the fetal brain: biological and pathological development. In The Fetal and Neonatal Brain Stem (ed. HansonM.A.), pp. 87–105. Cambridge, UK: Cambridge University Press.
21.
AshwalS.P., DaleP.S., & LongoL.D. (1984). Regional cerebral blood flow: studies in the fetal lamb during hypoxia, hypercapnia, acidosis and hypotension. Pediatric Research18, 1309–1316.
22.
GregoireN.M., GjeddeA., PlumF., & DuffyT.E. (1978). Cerebral blood flow and cerebral metabolic rates for oxygen, glucose, and ketone bodies in newborn dogs. Journal of Neurochemistry30, 63–69.
23.
JensenA. (1996). The brain of the asphyxiated fetus — basic research. European Journal of Obstetrics & Gynecology and Reproductive Biology65, 19–24.
24.
PotterV.R., SchneiderW.C., & LieblG.J. (1945). Enzyme changes during growth and differentiation in the tissues of the rat. Cancer Research5, 21–24.
25.
ZarchinN., & MayevskyA. (1981). The effects of age on the metabolic and electrical responses to decapitation in the awake and the anaesthetized rat brain. Mechanisms of Ageing and Development16, 285–294.
26.
LagercrantzH., & SlotkinH. (1986). The “stress” of being born. Scientific American254, 92–102.
27.
CarrB.R. (1993). Fertilization, implantation and endocrinology of pregnancy. In Textbook of Endocrine Physiology, 2nd edition, (ed. GriffinJ.E., & OjedaS.R.), pp. 189–209. Oxford, UK: Oxford University Press.
28.
HansonM. (1992). The control of the fetal circulation. In The Fetal and Neonatal Brain Stem (ed. HansonM.A.), pp. 59–85. Cambridge, UK: Cambridge University Press.
29.
JansenA.H., BelikJ., IoffeS., & ChernickV. (1989). Control of organ blood flow in fetal sheep during normoxia and hypoxia. American Journal of Physiology257, 1132–1139.
30.
BlackmoreD.K. (1984). Differences in behaviour between sheep and cattle during slaughter. Research in Veterinary Science37, 223–226.
GluckmanP.D., WilliamsC.E., & GunnA.J. (1992). Brain stem and cerebral function in the fetus: its assessment and the impact of asphyxia. In The Fetal and Neonatal Brain Stem (ed. HansonM.A.), pp. 185–210. Cambridge, UK: Cambridge University Press.
33.
ReillyJ.S., ed. (1993). Euthanasia of Animals Used for Scientific Purposes, 73 pp. Glen Osmond, Australia: Australian and New Zealand Council for the Care of Animals in Research and Teaching.
34.
de BooM. (1997). Pijn is nergens goed voor. Hypothese12, 4–5.
35.
Lord Rawlinson of Ewell, AltonD., AmesD., BoothH., ColchesterC., BaronessCox, FarmerA., FrancoiseC., GormallyF., GraffiusC., HendronJ., JacobovirsLord, Langdon-StokesM., Baroness Masham of Ilton, McLeanJ., MooreP., NolanM., Countess Quintavalle, ScarisbrickJ., TaylorR., WhiteM., WyattJ., & BartleyJ. (1996). Report of the Commission of Inquiry into Fetal Sentience, 24 pp. London, UK: CARE Trust.
36.
GradinM. (2000). Need for a reliable pain evaluation scale in the newborn in Sweden. Acta Anaesthesiologica Scandanavica44, 552–554.
37.
van DijkM., de BoerJ.B., KootH.M., TibboelD., PasschierJ., & DuivenvoordenH.J. (2000). The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0- to 3-year-old infants. Pain84, 367–377.
38.
Van LingenR.A. (2000). Pain assessment and Analgesia in the Newborn: an Integrated Approach, 177 pp. Rotterdam, The Netherlands: Erasmus University.
39.
BallantyneM., StevensB., McAllisterM., DionneK., & JackA. (1999). Validation of the premature infant pain profile in the clinical setting. The Clinical Journal of Pain15, 297–303.
40.
ScottC.S., RiggsK.W., LingE.W., FitzgeraldC.E., HillM.L., GrunauR.V., SolimanoA., & CraigK.D. (1999). Morphine pharmacokinetics and pain assessment in premature newborns. Journal of Pediatrics135, 423–429.
41.
BeaverB.V., ReedW., LearyS., McKiernanB., BainF., SchultzR., Taylor BennetB., PascoeP., ShullE., CorkL.C., Francis-FloydR., AmassK.D., JohnsonR., SchmidtR.H., UnderwoodW., ThorntonG.W., & KohnB. (2000). 2000 Report of the AVMA panel on euthanasia. Journal of the American Veterinary Medical Association218, 669–696.
42.
MerskeyH., Albe-FessardD.G., BonicaJ.J., CarmonA., DubnerR., KerrF.W.L., LindblomU., MumfordJ.M., NathanP.W., NoordenbosW., PagniC.A., RenaerM.J., SternbachR.A., & SunderlandS. (1979). Pain terms: a list with definitions and notes on usage: recommended by the IASP Subcommittee on Taxonomy. Pain6, 249–252.
43.
JessellT.M., & KellyD.D. (1991). Pain and analgesia. In Principles of Neural Science, 3rd edn (ed. KandelE.R., SchwartzJ.H., & JessellT. M.), 1135 pp. London, UK: Prentice-Hall International.
44.
CloseB., BanisterK., BaumansV., BernothE.M., BromageN., BunyanJ., ErhardtW., FlecknellP., GregoryN., HackbarthH., MortonD., & WarwickC. (1996). Recommendations for euthanasia of experimental animals: part 1. Laboratory Animals30, 293–316.
45.
KitchellR.L. (1987). Problems in defining pain and peripheral mechanisms of pain. Journal of the American Veterinary Medical Association191, 1195–1199.
46.
Anon. (1995). Code of Recommendations and Minimum Standards for the Care and Use of Animals for Scientific Purposes, 63 pp. Wellington, New Zealand: Ministry of Agriculture and Fisheries, Animal Welfare Advisory Committee.
47.
Anon. (1990). Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 5th edn, 75 pp. Canberra, Australia: Australian Government Publishing Service.
48.
FlecknellP.A. (1984). The relief of pain in laboratory animals. Laboratory Animals18, 147–160.
49.
WallaceJ., StanfordJ., SmithM.W., & SpencerK.V. (1990). The assessment and control of the severity of scientific procedures on laboratory animals. Laboratory Animals24, 97–130.
50.
BaumansV., BrainP.F., BrugéreH., ClausingP., JeneskogP., & PerretaG. (1994). Pain and distress in laboratory rodents and lagomorphs. Laboratory Animals28, 97–112.
FitzgeraldM. (1994). Neurobiology of fetal and neonatal pain. In Textbook of Pain, 3rd edn. (ed. WallP.D., & MelzackR.), pp. 153–163. London, UK: Churchill Livingstone.
53.
VanhataloS., & van NieuwenhuizenO. (2000). Fetal pain?Brain and Development22, 145–50.
54.
WiseJ. (1997). Fetuses cannot feel pain before 26 weeks. British Medical Journal315, 1111–1116.
55.
CloseB., BanisterK., BaumansV., BernothE.M., BromageN., BunyanJ., ErhardtW., FlecknellP., GregoryN., HackbarthH., MortonD., & WarwickC. (1997). Recommendations for euthanasia of experimental animals: part 2. Laboratory Animals31, 1–32.
56.
TermanG.W., ShavitY., LewisJ.W., CannonJ.T., & LiebeskindJ.C. (1984). Intrinsic mechanisms of pain inhibition: activation by stress. Science, New York226, 1270–1277.
57.
PatersonD.J., RobsonL.E., & KosterlitzH.W. (1983). Classification of opioid receptors. British Medical Bulletin39, 31–36.
58.
FitzgeraldM. (1992). The development of descending brain stem control of spinal cord sensory processing. In The Fetal and Neonatal Brain Stem (ed. HansonM.A.), pp. 127–135. Cambridge, UK: Cambridge University Press.
59.
LagercrantzH., & ForssbergH. (1991). Hjärmans funktionella utveckling hos fostret och spädbarnet. Nordisk Medicin106, 264–268.
60.
del FiaccoM., DessiM.L., & LevantiM.C. (1984). Topographical localization of substance P in the human post mortem brain stem: an immunohisto-chemical study in the newborn and adult tissue. Neuroscience12, 591–611.
61.
LagercrantzH., & SrinivasanM. (1992). Development and function of neurotransmitter/modulator systems in the brain stem. In The Fetal and Neonatal Brain Stem (ed. HansonM.A.), pp. 1–19. Cambridge, UK: Cambridge University Press.
62.
McCullaghP. (1997). Do fetuses feel pain? Can fetal suffering be excluded beyond reasonable doubt?British Medical Journal314, 302.
63.
SaundersP.J. (1997). Do fetuses feel pain? We should give them the benefit of the doubt. British Medical Journal314, 302.
64.
Bernstein, et al. quoted by HepperP.G. (1992). Fetal psychology: an embryonic science. In Fetal Behaviour (ed. NijhuisJ.G.), pp. 129–156. Oxford, UK: Oxford Medical Publications.
65.
GagnonR. (1992). Fetal behaviour in relation to stimulation. In Fetal Behaviour (ed. NijhuisJ.G.), pp. 209–226. Oxford, UK: Oxford Medical Publications.
66.
RoweM. (1992). Coding of tactile information in the developing nervous system. In The Fetal and Neonatal Brain Stem (ed. HansonM.A.), pp. 137–160. Cambridge, UK: Cambridge University Press.
67.
JohnsonR.W. (1995). Fetal bovine serum: optimizing cell culture media (reprinted from IVD Technology, February 1995), 3 pp. Verviers, Belgium: Boehringer Ingelheim Bioproducts.
68.
HonnK.V., SingleyJ.A., & ChavinW. (1975). Fetal bovine serum: a multivariate standard. Proceedings of the Society for Experimental Biology and Medicine149, 344–347.
69.
PriceJ.P., & GregoryE.A. (1980). Relationship Between In Vitro Growth Promotion and Biophysical and Biochemical Properties of the Serum Supplement: Version of Submission, 18 pp. Berlin, Germany: Biochrom Beteiligungs
70.
KnepperP.A., MayanilC.S., GoossensW., McLoneD.G., & HayesE. (1998). The presence of transcription factors in fetal bovine sera. In Vitro Cellular and Developmental Biology: Animal34, 170–173.
71.
NewmanK.Jr. (2000). Serum-Free Systems: Essential for Critical Work and Contemporary Routine Tissue Culture.St Paul, MN, USA: Celox Laboratories. Web site: http://www.celox/comsrmfree.htm (Accessed 13.2.02).
72.
DeFrancescoL. (1998). Serum-free cell culture. The Scientist, New York12, 19–21.
73.
BrunoJ.G., HermanT.S., CanoV.L., StriblingL., & KielJ.L. (1999). Selective cytotoxicity of 3-amino-l-tyrosine correlates with peroxidase activity. In Vitro Cellular and Developmental Biology: Animal35, 376–382.
74.
YangF., Abdel-MalekZ., & BoissyR.E. (1999). Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocyte. In Vitro Cellular and Developmental Biology: Animal35, 566–570.
75.
PeehlD.M., SellersR.G., & WongS.T. (1998). Defined medium for normal adult human prostatic stromal cells. In Vitro Cellular and Developmental Biology: Animal34, 555–561.
76.
Bulic-JakušF., VlahovicM., Juric-LekicG., Crnek-KunsteljV., & ŠermanD. (1999). Gastrulating rat embryo in a serum-free culture model: changes of development caused by teratogen 5-azacytidine. ATLA27, 925–933.
77.
SobreroA.F., & BertinoJ.R. (1986). Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum. International Journal of Cell Cloning4, 51–62.
78.
KatayamaH., KinoJ., ItamiS., TsutsuiM., KoizumiH., HalprinK.M., & AdachiK. (1986). A cell-spreading inhibitor exists in serum and in epidermal basal cells. Journal of Investigative Dermatology86, 694–699.
79.
SumterR.D. (1993). Literatuur onderzoek naar het potentieel gebruik van foetaal kalfserum in industrie en onderzoeksinstituten, 36 pp. Utrecht, The Netherlands: Utrecht University.
80.
EricksonG.A., BolinS.R., & LandgrafJ.E. (1991). Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. Developments in Biological Standardization75, 173–175.
81.
Anon. (1996). Guidelines for the Welfare of Livestock from which Blood is Harvested for Commercial and Research Purposes, 15 pp. Wellington, New Zealand: Ministry of Agriculture, Animal Welfare Advisory Committee.
82.
KajanderE.O., KuronenI., & CiftciogluN. (1996). Fatal (fetal) bovine serum: discovery of nanobacte-ria. Molecular and Cellular Biology, Suppl. 1, 7, 517a.
83.
CiftciogluN., HiltunenE., AkermanK., & KajanderE.O. (1996). Apoptotic effect of nanobacte-ria on cultured mammalian cells. Molecular and Cellular Biology7, 517a.
84.
CiftciogluN., KuronenI., AkermanK., HiltunenE., LaukkanenJ., & KajanderE.O. (1997). A new potential threat in antigen and antibody products: nanobac-teria. In Vaccines 97 (ed. BrownF., BurtonD., DohertyP., MekalanosJ., & NorrbyE.), 367 pp. New York, US: Cold Spring Harbor Laboratory Press.
85.
AnguloA.F., ReijgersR., BrugmanJ., KroesenI., HekkensF.E.N., CarleP., BovéJ.M., TullyJ.G., HillA.C., SchoulsL.M., SchotC.S., RohollP.J.M., & PolakVogelzangA.A. (2000). Acholeplasma vituli sp. nov., from bovine serum and cell cultures. International Journal of Systematic and Evolutionary Microbiology50, 1125–1131.
YuanLongP., BenderP.K., AkersR.M., & WebbK.E.J. (1998). One or more serum factors promote peptide utilization in cultured animal cells. Journal of Nutrition128, 744–750.
RussellW.M.S. (1999). The progress of humane experimental technique. ATLA27, 915–922.
90.
StafleuF.R., RivasE., RivasT., VorstenboschJ., HeegerF.J., & BeynenA.C. (1992). The use of analogous reasoning for assessing discomfort in laboratory animals. Animal Welfare1, 77–84.
91.
JondorfW.R., MaickelR.P., & BrodieB.B. (1958). Inability of newborn mice and guinea pigs to metabolise drugs. Biochemical Pharmacology1, 352–354.
92.
de JagerC. (1991). De wetenschappelijke methoden. Skeptische Notities7, 8–27.
93.
ArnaudP., PaddockG.V., & DolanJ.W. (2001). A replacement for fetal bovine serum: recombinant fetuin?Alternatives Today1, 8.
94.
RizzinoA., RizzinoH., & SatoG. (1979). Defined media and the determination of nutritional and hormonal requirements of mammalian cells in culture. Nutrition Reviews37, 369–376.
95.
KimE.J., KimN.S., & LeeG.M. (1999). Development of a serum-free medium for dihydrofolate reductase-deficient Chinese hamster ovary cells (DG44) using a statistical design: beneficial effect of weaning of cells. In Vitro Cellular and Developmental Biology: Animal35, 178–182.
